rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Personalized cancer chemotherapy
    sub title: an effective way of enhancing outcomes in clinics
  name:
    name part: Lu, Da-Yong
    name part: 1962-
    role:
      role term: creator
    role:
      role term: author.
  name:
    name part: ScienceDirect (Online service)
  type of resource: text
  genre: bibliography
  genre: Electronic books.
  origin info:
    place:
      place term: enk
    date issued: 2015
    copyright date: 2015
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource (85 pages) : illustrations (some color)
  abstract: Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists.
  table of contents: Introduction -- Drug sensitivity testing -- Individualized cancer chemotherapy via cancer biomarkers or bioinformatics detection -- Pharmacogenetics -- Individualized antimetastatic therapy [1-2] -- Drug combinations -- Assistant chemotherapy -- Cost-effectiveness considerations -- Discussion -- Conclusion.
  note: Da-Yong Lu.
  note: Includes bibliographical references.
  subject:
    topic: Chemotherapy
  subject:
    topic: Cancer
    topic: Treatment
  subject:
    topic: Antineoplastic agents
  subject:
    topic: Antimitotic agents
  subject:
    topic: Drugs
    topic: Side effects
  subject:
    topic: Neoplasms
    topic: drug therapy
  subject:
    topic: Drug Therapy
  subject:
    topic: Antimitotic Agents
  subject:
    topic: Antineoplastic Agents
  subject:
    topic: Drug-Related Side Effects and Adverse Reactions
  subject:
    topic: Pharmacogenetics
    topic: methods
  subject:
    topic: Precision Medicine
    topic: methods
  subject:
    topic: Chimiothérapie
  subject:
    topic: Cancer
    topic: Traitement
  subject:
    topic: Anticancéreux
  subject:
    topic: Médicaments
    topic: Effets secondaires
  subject:
    topic: MEDICAL
    topic: Pharmacology
  subject:
    topic: Drugs
    topic: Side effects
  subject:
    topic: Antineoplastic agents
  subject:
    topic: Antimitotic agents
  subject:
    topic: Cancer
    topic: Treatment
  subject:
    topic: Chemotherapy
  classification: RM263
  classification: 615.58
  classification: QV 267
  related item:
    title info:
      title: Personalized Cancer Chemotherapy
    origin info:
      publisher: Woodhead Pub Ltd 2014
    identifier: (DLC) 2014957608
    identifier: (OCoLC)898160939
  related item:
    title info:
      title: Woodhead Publishing series in biomedicine ; no. 720
  identifier: 9780081003473
  identifier: 0081003471
  identifier: 9780081003466
  identifier: 0081003463
  identifier: 8784386620535062620 TotalBoox
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: EBLCP
    record creation date: 141220
    record change date: 20260326212734.0
    record identifier: in00005758553
    language of cataloging:
      language term: eng